Zak Mir talks to Tim McCarthy, CEO Immupharma
12 September 2025
Zak Mir talks to Tim McCarthy, CEO Immupharma, in the wake of the specialty biopharmaceutical company that discovers and develops peptide-based therapeutics, announcing the filing of a groundbreaking new patent application for its lead asset P140, the world’s first “Immunormalizer.”